1.Effect on cell apoptosis and Bax/Bcl-2 gene expression of implanted human breast cancer cells in nude mice by applying RNAi to silence STAT3 gene
Yu WANG ; Yingchao ZHANG ; Yuzhuo PAN ; Xuejian ZHAO ; Wenzeng GUAN
Chinese Journal of General Surgery 1997;0(04):-
0.05). Conclusions Silencing STAT3 gene can decrease STAT3 gene expressions , increase Bax gene expressions , induce cell apoptosis and suppress the tumor growth in the human breast carcinoma model by the RNAi technology .
2.Early response and acute adverse effect after particle radiation therapy for adenoid cystic carcinoma of the head and neck
Jing GAO ; Lin KONG ; Xiyin GUAN ; Jiyi HU ; Xiaofei ZHANG ; Yingchao ZHU ; Jiade LU
Chinese Journal of Radiological Medicine and Protection 2016;36(8):607-610
Objective To study the early response and acute/subacute adverse effects after particle radiation therapy for adenoid cystic carcinoma (ACC) of the head and neck.Methods Between May 2015 and March 2016,a total of 8 patients with ACC of the head and neck were treated using proton and/or carbon-ion radiation therapy.Three patients had early stage and 5 had locally advanced disease.Five patients had an R2 and three achieved an R1 resection.Results Seven patients received intensitymodulated proton therapy (IMPT) followed by intensity-modulated carbon-ion therapy (IMCT) boost.One patient received IMPT only.Among the five patients who had an R2 resection,2/3 patients had partial response (PR)/stable disease (SD) at the end of radiation,0/3 achieved PR/complete response (CR) at 1-month follow-up,and 1/2 achieved PR/CR at 3-months' follow-up after the completion of radiation,respectively.Two patients experienced Grade Ⅲ mucositis during radiation therapy.No patient experienced moderate or severe skin reactions.At the time of this analysis,all patients are alive and no patient had disease progression or recurrence.Conclusions The short-term outcomes indicated that particle therapy is safe and potentially efficacious in the management of head and neck ACC.However,longer follow up is needed to assess late toxicities and long-term efficacy.
3.Clinical features and prognosis of purulent meningitis in premature infants versus full-term infants
Hanzhou GUAN ; Hai LI ; Yingchao FAN ; Ying GUO ; Xinhua ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2021;28(8):1164-1167
Objective:To investigate clinical features and prognosis of purulent meningitis in premature infants versus full-term infants and to better understand purulent meningitis and improve the diagnosis and treatment of purulent meningitis in infants. Methods:The clinical data of 54 infants with purulent meningitis who received treatment in Shanxi Children's Hospital, China between January 2017 and December 2019 were included in this study. The included infants were divided into preterm group (gestational age < 37 weeks, n = 11) and full-term group (gestational age 37-42 weeks, n = 43) according to different gestational ages. Clinical features and cerebrospinal fluid biochemical indexes (white blood cell count, protein concentration, glucose level) as well as total effective rate were compared between the preterm and full-term groups. Results:The main clinical features of neonatal purulent meningitis were fever, bradykinesia, low amount of milk intake, convulsion, lethargy, irritability, increased intracranial pressure, hypotonia or hypertonia. Hypotonia was the prominent manifestation in the preterm group, while fever, convulsion and bradykinesia were the prominent manifestations in the full-term group. White blood cell count and cerebrospinal fluid glucose level in the preterm group were significantly higher than those in the full-term group ( t = 2.215, 2.023, both P < 0.05), but cerebrospinal fluid protein level in the preterm group was significantly higher than that in the full-term group ( t = 2.437, P < 0.05). There was no significant difference in total effective rate between preterm and full-term groups [90.91% (10/11) vs. 90.70% (39/43), χ2 = 0.001, P > 0.05]. Conclusion:The clinical features of neonatal purulent meningitis are not specific, and the clinical features of premature infants with purulent meningitis are not typical. It is necessary to carefully observe the clinical manifestations of premature infants with purulent meningitis and detect the biochemical indexes of cerebrospinal fluid to strive for early diagnosis and treatment.
4.Application progress of esketamine in gynecology and obstetrics during perioperative period
Xiaojing CONG ; Yingchao GUAN ; Songyang YU
Chinese Journal of Pharmacoepidemiology 2024;33(6):697-706
The volume of gynecological and obstetric surgeries is large,and the high rates of adverse events incidence such as perioperative cycle fluctuations,postoperative nausea and vomiting and adverse emotional experiences,which is a concern for clinicians.Esketamine is a right-handed isomer of ketamine with a strong affinity for the N-methyl-D-aspartate receptor(NMDAR),which has a rapid anesthetic,analgesic and antidepressant effect.It can be administered through multiple routes and has been widely used in clinical anesthesia,postoperative analgesia and depression treatment.The application of esketamine injection in clinical practice is still relatively short,and the benefits and mechanisms during perioperative application have not been fully elucidated,making it a research hotspot in recent years.Many studies have reported that the application of esketamine injection in obstetrics and gynecology surgery can stabilize circulation,and reduce respiratory depression,nausea and vomiting and other adverse reactions.It is also beneficial for the prevention and treatment of postpartum depression under certain conditions,but sometimes there are also temporary pseudo-psychiatric symptoms and other adverse reactions.In this article,we review the pharmacological effects,perioperative application and impact on postoperative recovery of esketamine based on the specialty characteristics of obstetrics and gynecology surgery,and clarify its current application status,as well as possible clinical applications and research directions in the future,to provide reference for the clinicians.
5.Analysis of the implementation of health impact assessment of public policies in Zhejiang province
Shuai GUAN ; Hailing YANG ; Yanyun XU ; Yingchao FENG ; Min SHI ; Lan DING ; Bo XU ; Yunzhou SUN ; Meng ZHANG
Chinese Journal of Hospital Administration 2022;38(6):416-420
The policy implementation model of G. C. Edwards was used to analyze the public policy health impact assessment in Zhejiang province, and summarize its practice and existing problems in four aspects of policy implementation standards, policy resources, policy executors′ intention and management organization structure, so as to provide reference for promoting the national health impact assessment pilot work. The analysis results showed that Zhejiang province has initially established the public policy health impact assessment mechanism and achieved phased results, but there were still some problems, including the imperfection of policy content and implementation strategy, the inadequacy of leadership decision-making and top-level design, the difference in attitude, understanding and implementation preference of policy implementation subjects, and the ambiguity of the authority and responsibility system of each department in cooperation. In order to further promote the smooth development of public policy health impact assessment, Zhejiang province should actively promote the top-level design to strengthen policy support, integrate and optimize policy resources, gradually establish and improve the health governance mechanism of multiple and overall coordination, and promote the high-quality development of public policy health impact assessment by taking cross departmental cooperation as the path of health co-construction.